Member Info for ratcliffewriter

Oh drac, you're definitely on the wrong board for a comment like that!! Pmsl.

From the point of view of raising capital, what puts money into a company? Someone buying shares already in circulation or someone putting capital into a company, whether by share issue or some kind of deal? Obviously share issue is to be done with caution due to dilution (obvs) and most important of all is what the company does with the money raised. But you know that anyway.

The CF shares weren't immediately on the open market, and while any purchase of them by an interested Bio would have given the sp a boost and helped trading and short term profits for trading, it would not have put a single penny into the company so would not have helped the science get developed at all. As you say, we will have to differ on that one. Thanks for the reminder - I've just remembered who the 'second hand shareholder' term came from. He was right on that one too, as history shows.

If I were a larger bio wanting a stake in a smaller one, I'd go for some form of issuing of new shares to put working capital into the company, especially if their science lined up with my own - that way they get a stake AND provide money to further any work. That level of cooperation would require some serious negotiations. Buying of shares on the open market would make one what the uncaring and cynical might call a 'second hand shareholder' - it would not provide a penny of working capital, just an investment for the buyer. Not a nice term, 'second hand shareholder, and one for perhaps the more cynical and uncaring, but I'm sure you know what I mean.

It's something that is easily overlooked, or at least maybe not accorded its true significance. As you will know RP, many a time you see a small bio with work that 'ought' to fit with a larger one, and on their bb you will see very genuine comments of 'Astra Zeneca/Takeda/GSK should be all over this one', but they never are. So the next big step is that they actually do show an interest. The bigger step beyond that is when they maintain an interest or increase it - as BioNtech have conspicuously done, along with Genentech and Roche who have Scancell firmly on the radar. Then add Ugur Sahin, Keith Flaherty and a good number of others, and the ingredients in the melting pot get very tasty. Moditope has been slow, but in truth 6 years of development and possible discussions is not an eternity, (it's a reasonable timescale if you have serious stuff going on) and during all that time the interest from respected outsiders has increased, as has the interest in oncimmunotherapy. We can guess at the future, but you can't deny the present. As I say, the company you keep is easy to overlook, and with Scancell being so very low key from a PR point of view it is all very subtle. Obviously the approach of the end of the collaboration period with BioNtech coupled with Friday's RNS make for interesting conjecture for the near term as well as the longer term. The mass dump of CF shares was a shock when it happened, but it certainly clears the air for a much more constructive path for the sp on any news or raising of expectations. Only now they are gone does it make me realise how much of a shadow it was casting, with a large pool of shares free to be drawn upon and sold into any rise - well that isn't an option now. I'll be interested to see what news next week and beyond may bring.

Certainly worth spending some time researching Moditope properly to get an idea of its potential and its pre-clinical results so far. Also worth looking at the names closely associated with it - the sort of people and resources you really welcome having in close association with this sort of science.

Or open to scrutiny and prepared to see the points of others. Anyway, Saturday nights at your house must be almost as riveting as at mine. We should get together over a mug of cocoa and a black and white Ealing comedy repeat some time.

Indeed it was year 1970, not your good self - sorry, but you both seem to have a lot in common don't you think? My memory corrected by looking back on the posts. Perhaps by way of balance and civil exchange you could now reciprocate and 'name and shame' your mythical 'team ramp' - posting names only, not real ones of course. A few summaries of what they have said that you find so offensive, unless they are only a figment of your own imagination. It would be an interesting topic to discuss if you are so inclined. Correcting inaccuracies is useful.

Why not clear the air - put names to 'team ramp' and a few cut and pastes to back up that rather hysterical allegation. I'm sure it would be very informative for anyone looking in. Unless you're just acting as a rather sad puppet for the many who got themselves banned from here for lies and abuse. I'm very happy to hear alternative views, provided they're backed by reasonable facts (unlike your ridiculous posting from the other night which was shot down in flames with some links proving you were very far from the truth). And it's 'you're only here', not 'your only here.' Sorry to appear pedantic, but checking what you actually post might help you. Or are you just being vindictive because that's your nature? I hope not, as we seem to have some nice reassuring common ground. Why not try to calm down and build on that eh?

Moral not morale, and 'you're claiming' not 'your claiming.' I've never made any share price prediction of you'd care to check, I retain my optimism for the future of scancell, as indeed do you it seems. I don't see why you are being quite so abusive, but maybe that's just how you come across. Perhaps you should take a deep breath and try again when you're a bit calmer. It would make for a nicer and more constructive board.

Where does Misterpositive sit within the trading fraternity then?

I don't see why you are getting so steamed up about this knowlesi - as C7 says, life is too short. It is good that we agree that Scancell looks set for a prosperous future, but where it goes on its journey to prosperity is anyone's guess. It is normal to base one's hopes on (as they say in driving) 'what you can see, what you can't see, and what you can reasonably expect to develop.' It just seems a little indecisive and fruitless to try to cover all bases as a sort of 'posting insurance policy' for a little more perceived authority further down the line, but whatever floats your boat I suppose. Just one thing though, you refer to me in quite a vitriolic way as a 'ramper.' Please show me where any of my posts qualify for that label - I suspect it is just used in an attempt to provoke, which is really unnecessary, and results in you not being a thorn in my side by any means, but maybe occasionally a dull ache in a more fundamental part of the anatomy. Have a good day anyway. C7 - delighted with your successful surgery, look forward to more of your insights as we watch and wait.

A perfect example of why you command the level of respect that you do knowlesi - you say 'I expect further weakness' and you expect it will come good. In due course you will be proven to have predicted the future with unparalleled clarity. How do you manage it? I stand in awe of you. Night night.

Clear as mud Knowlesi, I think we can assume that whatever happens you will have called it right with your usual hindsight. Again. I presume you are descended from the Oracle of Delphi.

So you think they're heading down the pan then?

You haven't answered my question to you knowlesi, so I'll put it in simpler terms - do you think the company is going to sail blindfolded into bankruptcy or do you think they might have developed some sensible money plans alongside the science development?

Serious question knowlesi - do you think the BoD have gone this far without a plan for finance and will wake up one day soon and think 'Oh fork in hell, we forgot about the money', or do you think there may be plans in place that involve funds from other sources than a placing, especially as the BoD are painfully aware of the share price graph and its similarity to an alpine meadow?

Ooh you little ramper you. (But yes, a buy)

I think you can say with certainty that VAL has no rivals.

Nice to see nobody has stooped so low as to mention which shares are where on the risers and fallers board as was done on Tuesday so distastefully lol.